Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Private sector revives the climate disaster database Trump tried to squash - 2Fabricated statement about Malaysian national exam top scorers stokes racial sentiment
- 3Artemis II shares new lunar images while more than halfway to the moon
- 4AI’s errors may be impossible to eliminate – what that means for its use in health care
- 5'Not the moon that I'm used to seeing': Artemis II astronauts describe seeing the far side
- Rights group: At least 2,500 deaths during protest crackdown in Iran
- Scientists captured female sperm whales on video working together during a birth to protect the calf
- We may have less control over how long we live than previously thought
- Artemis 2 astronauts — now halfway to the moon — report 'burning smell' from toilet, but everything's fine
- Tributes pour in for MIT professor Nuno Loureiro amid unresolved shooting case
- Smuggler who called migrants 'chickens' jailed
- Hot Electric Vehicles for 2023
- What we know about Jonathan Ross, the ICE agent who shot and killed Renee Nicole Good in Minneapolis
- Pick Your #1 breakfast food
